30.4 C
Vientiane
Thursday, August 21, 2025
spot_img
Home Blog Page 655

JIMMY Launches R9 Countertop RO Water Purifier: The Ultimate Mother’s Day Gift for Safe, Pure, and Convenient Hydration

Ultra-thin and free-installation design with UV sterilization and instant heating to simplify your life with pure water anytime

NEW YORK, May 2, 2025 /PRNewswire/ — This Mother’s Day, JIMMY is celebrating mothers worldwide with the launch of the innovative Countertop RO Water Purifier R9. Thoughtfully designed as the perfect gift, JIMMY R9 shows appreciation for everything moms do, bringing heartfelt wishes into their daily routines. More than just a purifier, JIMMY R9 delivers high-quality, mother-and-infant-safe drinking water turning everyday hydration into an act of care for the whole family.

 

JIMMY Countertop RO Water Purifier R9

Whether it’s preparing 110°F warm water for mom’s formula, brewing 200°F coffee for dad, serving chilled mineral water for the kids, or offering fresh water for pets, JIMMY R9 ensures that every member of the family can enjoy safe, delicious, and easily accessible water. JIMMY has always been dedicated to meeting consumers’ everyday needs in the home appliance sector. With this groundbreaking water purification technology, JIMMY R9 is redefining what it means to have fresh, healthy, great-tasting water on demand—setting a new standard for direct-purified water with precise temperature control.

Comprehensive Home Water Solutions: Making Healthy Purity Easily Accessible

  • Installation-Free Ultra-Thin Design: JIMMY R9 features an ultra-slim profile of just 9.9 inches, allowing for effortless placement in various spaces—no installation required. Its sleek, modern look integrates seamlessly into kitchen or living room decor, enhancing your home’s overall aesthetic.
  • 7-Stage Purification for Exceptional Taste: JIMMY R9 features a mother-and-infant-grade, 7-stage purification system with 0.0001-micron RO reverse osmosis and UV sterilization. This advanced process removes 99.99% of bacteria, heavy metals, PFAS, and other harmful substances. Certified by trusted international organizations (SGS, FDA, FCC), and enhanced with coconut shell activated carbon, JIMMY R9 ensures water that tastes as pure and fresh as spring water—delivering true peace of mind for every family.
  • Precise Temperature and Quantity Control: Thanks to advanced 3-second rapid heating technology, JIMMY R9 delivers precise temperature control from room temperature up to 200°F. With seven customizable settings, it meets diverse beverage needs—whether for coffee, hot tea, or milk frothing. The precise water temperature and volume setting allows busy moms to enjoy truly worry-free preparation of formula milk.

User Friendly Design for Convenient Use: Greatly Simply Your Life

  • Clean Water, Anytime, Anywhere:
    JIMMY R9’s innovative design moves the water tank to the exterior, featuring two detachable, BPA-free Tritan water tanks. These can be placed in the fridge for chilled water. An integrated UV sterilization lamp at the rear of the tank eliminates 99.99% of bacteria, ensuring safe, convenient hydration for the whole family—at home or on the go.
  • Effortless User Convenience: With a simple, one-step filter replacement and a large 5L raw water tank, JIMMY R9 is built for everyday ease. The ergonomically positioned side tank makes refilling straightforward and seamless, enhancing the user experience.
  • Thoughtfully Designed Interactions: JIMMY R9 is equipped with an easy-to-use smart touch screen, enabling effortless selection of both water temperature and dispensing quantity. Personalized settings can be stored for different family members, making it simple for everyone to manage their preferences. The intelligent display provides real-time monitoring of TDS values before and after purification, as well as filter life status, ensuring transparency and peace of mind. Additional thoughtful features include a child lock to prevent accidental operation and a night light at the water outlet for added convenience during late-night use—demonstrating the R9’s attention to detail and commitment to family safety.

JIMMY R9 is more than a technological breakthrough—it’s a commitment to sustainable living. By replacing over 3,500 bottles of water each year with a single device, it encourages environmental conservation and reduces plastic waste, helping to protect our planet for future generations.

The JIMMY Countertop RO Water Purifier R9 is available on Amazon initially, followed by Best Buy listings soon.

About us

JIMMY, a technology-driven home appliance brand under KingClean Electric Co., LTD, with 31 years of expertise, is committed to providing healthy and convenient water solutions for families worldwide.

KingClean has focused on the environmental cleaning industry for 31 years since its establishment in 1994. The company has 800+ R&D engineers, files around 200 new patents annually, and holds 1,800+ patents. Leveraging KingClean’s robust R&D and production capabilities, JIMMY is committed to pioneering innovations that provide a cleaner way to enhance quality of life and overall well-being.

Contact: Sally.Hong@KingClean.com 

NYSE Content Advisory: Pre-Market update + China considering trade negotiations

NEW YORK, May 2, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on May 2nd

  • Stocks are fractionally higher this morning after the S&P 500 extended its win streak to eight straight sessions on Thursday. The index rose 0.6% as Microsoft and Meta shares rallied after better-than-expected results.
  • Overnight, China said its assessing possible trade talks with the U.S. and according to reports, it has started exempting some goods from levies that may cover about a quarter of its impact for the U.S.
  • Wall Street turns to April’s Jobs report this morning as forecasters estimate 133,000 jobs were added last month, down from 228,000 in March.

Opening Bell
Ring Magazine celebrates its first-ever boxing event in the United States, titled “FATAL FURY: City of the Wolves” tonight in Times Square.

Closing Bell
Carnival Corporation & plc (NYSE: CCL) counts down the days until it rings in a new tropical island paradise, Celebration Key.

Watch NYSE TV Live every weekday 9:00-10:00am ET

 

The 137th Canton Fair Sees a Booming Market for All-Age Toys

GUANGZHOU, China, May 2, 2025 /PRNewswire/ — Phase 3 of the 137th China Import and Export Fair (Canton Fair), held from May 1 to 5, features 11,759 export exhibitors under the theme “Better Life.” The event sees the shifting dynamics of the global toy industry, emphasizing how Chinese manufacturers are both responding to and shaping the rising demand for toys that appeal not only to children but to consumers of all ages.

Shantou City Chenghai Area Huada Toy Co., Ltd., a veteran in plastic building blocks manufacturing and export, brought a vibrant wall of lifelike flowers to its booth, entirely constructed from plastic building blocks. This creative installation not only turned heads but also highlighted the company’s latest product line, which reimagines building blocks as elegant, display-worthy decor. The featured floral series offers users the satisfaction of hands-on assembly combined with the aesthetic appeal of realistic artificial flowers. Once completed, these pieces can be used as stylish ornaments in homes or offices, bridging the gap between playful creativity and practical design.

“This collection reflects the evolution of toys,” said Chen Xiaowei, the company’s Deputy Marketing Director. “They’re no longer just for children. We’re seeing a growing trend among young adults who enjoy the process of building and the beauty of the finished product.” According to the company, its sub-brand PANLOS is specifically designed with this audience in mind, targeting consumers between 18 and 35.

Meanwhile, Guangdong SYMA Model Aircraft Industrial Co., Ltd drew attention with its latest range of aerial toys, including remote-controlled helicopters, foldable drones, and acrobatic flyers. Equipped with smart sensors and one-touch stunt features, these products provide an accessible entry point for both beginners and seasoned enthusiasts, catering to users of all ages, whether children or adults. Huang Zebin, Chief Marketing Officer of SYMA, emphasized that they consistently launch new products at the Canton Fair. “Given the scale of the event and the diversity of international buyers it attracts, the Fair often brings unexpected opportunities beyond our initial expectations,” he noted.

The rising popularity of “all-age toys” reflects a shift toward more experience-driven, emotionally engaging consumer preferences, prompting companies to rethink traditional product boundaries and uncover new growth opportunities. With a strong focus on advanced design, precision manufacturing, and user-centric innovation, Chinese suppliers are uniquely positioned to lead and scale in this rapidly growing global market.


 

BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem

CHENGDU, China, May 2, 2025 /PRNewswire/ — BGM Group Ltd. (Nasdaq: BGM) (the “Company” or “BGM”) , a leading AI technology company, today announced it has entered into a definitive agreement (the “Agreement”) to acquire HM Management Company Limited (“HM Management”), a prominent AI agent production platform, in an all-stock transaction valued at approximately RMB300 million (US$41.7 million).

Under the Agreement, BGM will issue 16,663,427 Class A ordinary shares at $2.50 per share to acquire 100% ownership of HM Management and its two wholly-owned subsidiaries: Beijing Shuda Technology Company Limited. (“Shuda Technology”) and New Media Star Technology (Shenzhen) Co., Ltd ( “New Media Star”). The transaction is expected to close in the second quarter of 2025, subject to customary closing conditions.

Shuda Technology is a high-tech company specializing in AI-driven enterprise efficiency solutions. By delivering integrated AI and data visualization solutions, it empowers businesses to conduct intelligent, end-to-end diagnostics and enhance decision-making across the entire innovation chain from research and development to commercialization, enabling rapid cost reduction, operational efficiency improvement, and business model innovation. New Media Star operates a fast-growing AI tools platform with over 150,000 followers, offering proprietary and third-party AI solutions for customer acquisition and private domain conversion.

Xin Chen, Chief Executive Officer of the Company, stated: “The addition of Shuda Technology and New Media Start introduces a disruptive engine to our strategy of building a multi-agentic production platform. Their matrix-based vertical industry agent cloning technology and AI visualization engine address a critical strategic gap, enabling us to foster technological creativity and drive industry-wide impact. This acquisition enhances our industry-specific AI DNA, allowing us to rapidly expand into vast market opportunities and create a leading ecosystem of AI agent applications. Their portfolio of over 100 industry-specific AI modules, along with an established developer ecosystem, will significantly accelerate our roadmap and secure a dominant position in the next-generation industry-specific AI operating systems.”

The acquisition expands the Company’s AI application portfolio and further integrates existing market resources from its AI insurance and AI mobility businesses, further solidifying the Company’s position in the AI industry.

About BGM Group Ltd.

BGM Group Ltd. has a strategic focus on the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals.

In terms of AI application implementation, the group relies on advanced analytics and AI Agent technology, and utilizes the two platforms of Du Xiao Bao and Bao Wang to provide comprehensive and professional AI solutions and intelligent robot services for insurance companies, insurance brokers, and consumers. Its services cover multiple key scenarios such as sales and marketing, underwriting assessment, claims processing, and customer service. The group is capable of analyzing consumer data, building consumer profiles, accurately predicting insurance needs, and providing highly customized services for consumers.

In the field of biopharmaceuticals, the group’s biopharmaceutical division mainly produces oxytetracycline API, crude heparin sodium, and licorice preparations, which are widely supplied to the global animal husbandry, pharmaceutical, and drug retail markets. The group deeply integrates AI-assisted decision-making into every link of production and manufacturing, achieving supply chain optimization, process efficiency improvement, and market trend prediction. This provides scientific decision-making basis for the management and offers high-quality products and precise services for consumers.

Forward-looking Statements

This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will”, “expects”, “anticipates”, “future”, “intends”, “plans”, “believes”, “estimates”, “target”, “going forward”, “outlook” and similar statements. Such statements are based upon management’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

For investor and media inquiries, please contact:
info@qiliancorp.com

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

PHILADELPHIA, May 2, 2025 /PRNewswire/ — Darnatein, a subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), a biotechnology company advancing design-augmented biologics, announced today that it will present scientific data at the 14th International Bone Morphogenetic Protein (BMP) Conference, taking place May 2–6, 2025, at the University of Pennsylvania in Philadelphia.

The BMP Conference brings together leading global researchers to explore the latest breakthroughs in BMP-related biology and regenerative medicine. This year’s program highlights novel technologies and fundamental research in tissue and organ regeneration. (https://www.14thbmpconference2025.com/)

Dr. Senyon “Teddy” Choe, CEO of Darnatein, will deliver a scientific presentation on May 3, titled:
“Design-Augmented Synthetic BMP Chimeras as Super-Agonists for Bone and Cartilage Regeneration.”

The presentation will showcase Darnatein’s proprietary platform technology that has led to the development of DRT-101 and DRT-102, two novel biologic candidates engineered to function as BMP super-agonists. DRT-101 with good preclinical safety profiles is being developed for joint cartilage regeneration, while DRT-102 is focused on spinal bone repair.

“This presentation reflects Darnatein’s growing leadership in synthetic regenerative biologics,” said Dr. Choe. “Our DA Biologics platform is enabling the creation of highly potent, next-generation growth factors with potential to transform musculoskeletal repair.”

Darnatein’s participation at the BMP Conference underscores a year of significant progress, including:

  • Preclinical validation of DRT-101 and DRT-102 demonstrating safety and enhanced regeneration of cartilage and bone tissue.
  • Ongoing IND-enabling studies in collaboration with BioToxTech, a publicly-listed CRO based in South Korea and the University of California, San Diego, aimed at advancing DRT-101 toward IND submissions with the Korean MFDS and U.S. FDA.

The company remains committed to expanding its Design-Augmented Biologics platform to address unmet needs in regenerative medicine globally.

About Darnatein

Darnatein is a biotechnology subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH) focused on the development of design-augmented biologics for regenerative medicine. The company’s proprietary platform harnesses synthetic biology and protein engineering to create next-generation growth factors for musculoskeletal and tissue repair. Lead candidates DRT-101 and DRT-102 are being developed for joint cartilage and spinal bone regeneration, respectively.

About OSR Holdings

OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. OSR aims to build and develop a robust portfolio of innovative and potentially transformative therapies and healthcare solutions. Its current operating businesses (through three wholly-owned subsidiaries) include (i) developing oral immunotherapies for the treatment of cancer (“Vaximm”), (ii) developing design-augmented biologics for age-related and other degenerative diseases (“Darnatein”) and (iii) neurovascular intervention medical device and systems distribution in Korea (“RMC”).  OSR’s vision is to acquire and operate a portfolio of innovative healthcare related companies globally.

Contact:
ir@osr-holdings.com

CPHI South East Asia 2025: Your gateway to ASEAN’s expanding pharmaceutical landscape

KUALA LUMPUR, Malaysia, May 2, 2025 /PRNewswire/ — As Southeast Asia’s pharmaceutical industry rapidly evolves—driven by regulatory harmonization, innovation, and growing healthcare demand—CPHI South East Asia 2025 provides a vital platform to connect with regional stakeholders, showcase breakthroughs, and unlock business opportunities across the ASEAN region.

CPHI South East Asia 2025 will be held from 16-18 July 2025 at MITEC, Kuala Lumpur, Malaysia
CPHI South East Asia 2025 will be held from 16-18 July 2025 at MITEC, Kuala Lumpur, Malaysia

Taking place for the first time in Kuala Lumpur, Malaysia, from 16–18 July 2025, the event will bring together 8,000+ professionals, 400+ global exhibitors, and curated buyers from across Asia and beyond—positioning it as the region’s most impactful pharma event.

Unlock Growth Across ASEAN’s Pharma Markets

From Indonesia, Thailand, Vietnam, the Philippines to Malaysia, Southeast Asia is one of the world’s most dynamic pharmaceutical regions. Governments are investing in local manufacturing, reforming regulatory systems, and opening doors to international partnerships.

Malaysia, as this year’s host, plays a central role in this growth. [1]The country’s pharmaceutical market is expected to rise from RM11.2 billion in 2022 to RM15.5 billion by 2027, supported by the New Industrial Master Plan (NIMP) 2030, which incentivizes the production of APIs, biologics, and vaccines.

[2] Strategically located between Singapore and Indonesia, Malaysia offers streamlined access to regional distributors, CDMOs, and packaging partners—making Kuala Lumpur a strategic gateway to ASEAN-wide expansion.

Source: 1. MIDA, MITI Malaysia

2. ASEAN Pharmaceutical Industry Report

At CPHI South East Asia 2025, you’ll be able to:

  • Access to high-growth markets across ASEAN with strong government backing for international pharma collaboration
  • First-mover advantage in a fresh, opportunity-rich environment
  • Direct connections with regional buyers, distributors, and contract manufacturers
  • Connect through strategic matchmaking with pre-qualified buyers from across ASEAN.

Event Highlights

  • Innovation Showcase
    Discover a broad spectrum of pharmaceutical innovations—from APIs, generic APIs, and excipients to biopharmaceuticals, herbal medicine, natural extracts, and finished dosage formulations. Explore the latest in custom manufacturing, drug delivery systems, pharma packaging, analytical & lab equipment, and pharmaceutical machinery & technology—all in one place.
  • Conference
    Hear from regulators, manufacturers, and experts on key topics including clinical trials, regulatory harmonization, and ASEAN market access.
  • Match & Meet (Business Matching Program)
    Connect through pre-arranged meetings with verified buyers actively sourcing products and partnerships.
  • Special Zones & Activities
    Discover immersive experiences and dedicated features including the International Pavilions, Sustainability Square, Pharma Quest (Competition), and more—designed to foster innovation, education, and cross-border collaboration.

Venue: MITEC, Kuala Lumpur
Dates: 16–18 July 2025
Explore more at:  https://www.cphi.com/sea

Register to visit at:  https://cphisea.imasia-passport.com/

The MarTech Summit Jakarta, 25 June 2025 at The St. Regis Jakarta

JAKARTA, Indonesia, May 2, 2025 /PRNewswire/ — Halo Jakarta! The MarTech Summit is returning to Jakarta for the third time, and this year’s theme is ‘Driving MarTech From Local Insights To Global Impact.’ Join us In-Person at The St. Regis Jakarta on 25 June 2025, the MarTech Summit will bring together 25+ MarTech thought leaders and 200+ attendees from all industries, exploring the latest MarTech developments and exchanging the insightful experiences.

Why Attend?

A Premium Experience at The St. Regis Jakarta
Set in the luxurious Caroline Astor Ballroom of The St. Regis Jakarta, this summit offers not only insightful discussions but also a premium culinary experience. Enjoy an elegant lunch and refreshments throughout the day, ensuring you’re well-fueled for a day of learning and networking.

Invaluable Learning Opportunities
Prepare to dive into a series of powerful sessions, including panel discussions, keynote presentations, fireside chats, and interactive roundtables. Whether you’re a CMO, Director, or Head of Marketing, you’ll leave equipped with the latest MarTech tools and strategies to enhance your marketing efforts.

Networking with Industry Leaders
This summit offers a unique platform to connect with fellow marketing professionals from across the region. Engage in meaningful discussions, exchange ideas, and expand your network to stay ahead in the ever-evolving world of MarTech.

Tailored Agenda for Indonesian Market
The agenda and speaker line-up are crafted specifically for the Indonesian MarTech trends and market, ensuring an insightful and relevant summit experience for all attendees!

English Speaking Summit
In Jakarta, one of the biggest APAC business centres, we bring together local and global speakers and attendees to participate in this English-speaking summit. Join the MarTech thought leaders of the region for the best discussion and interaction!

Don’t Miss Out!

Take advantage of our EARLY BIRD SALE – Save 20% off Summit Passes until 4 June 2025.

Venue: Caroline Astor Ballroom, The St. Regis Jakarta
Address: Rajawali Place, Jalan HR Rasuna Said Kav. B/4, Setiabudi, Jakarta Selatan 12190 Indonesia
Language: English

This is your chance to be part of an unparalleled MarTech event that blends learning, networking, and premium hospitality in one of Jakarta’s most prestigious venues.

What’s Going to Happen?

The 1-Day summit is packed with In-Summit Roundtables, Panel Discussions, Fireside Chats, Keynote Presentations, & Networking Sessions!

Our comprehensive agenda covers big MarTech topics:

  • Data-Driven Marketing: Customer Data Analytics, First-Party Data, Cookieless, Hyper-Personalisation, Data Communications & Mobile Apps Marketing
  • Customer Experience & Engagement: Social Media & Influencer Marketing, Omnichannel Marketing, Digital Experience & User Experience, User-Generated Content, Advanced CRM Strategies & Tools
  • Emerging Marketing Technologies: Location Marketing, GenAI & LLMs, Marketing Automation & Disruptive Technologies Integration
  • Digital Transformation: Digital Marketing Transformation, New Partnerships, Digital-First, Account Based Marketing, Conversational Marketing & MarTech Culture

There will be 25+ speakers from industry-leading companies, including Pizza Hut, Indopasifik Medika Investama, Honda Prospect Motor, Arista Group, SPH International Christian School, The Ascott Limited, Gojek, Viu, Sinar Mas & MORE!

Check out our confirmed speakers, and request the agenda here!

PR Newswire is the official Media Partner of The MarTech Summit Jakarta.

Reserve your seat and get the Super Early Bird discount by 30 March!  https://themartechsummit.com/jakarta-registration

Interested in becoming a partner? Don’t hesitate to get in touch with us at  sponsor@themartechsummit.com

Group rates are available upon request for 3+ attendees. Get a quote at  marketing@themartechsummit.com

Canadian Solar Schedules First Quarter 2025 Earnings Conference Call for May 15

KITCHENER, ON, May 2, 2025 /PRNewswire/ — Canadian Solar Inc. (“the Company”, “Canadian Solar”) (NASDAQ: CSIQ) today announced that it will hold a conference call on Thursday, May 15, 2025, at 8:00 a.m. U.S. Eastern Time (8:00 p.m., May 15, 2025, in Hong Kong) to discuss the Company’s first quarter 2025 results and business outlook.

The dial-in phone number for the live audio call is +1-877-704-4453 (toll-free from the U.S.), 800 965 561 (from Hong Kong), +86 400 120 2840 (local dial-in from Mainland China) or +1-201-389-0920 from international locations. The conference ID is 13753335. A live webcast of the conference call will also be available on the investor relations section of Canadian Solar’s website at www.canadiansolar.com.

A replay of the call will be available after the conclusion of the call until 11:00 p.m. U.S. Eastern Time on Thursday, May 29, 2025 (11:00 a.m. May 30, 2025, in Hong Kong) and can be accessed by dialing +1-844-512-2921 (toll-free from the U.S.) or +1-412-317-6671 from international locations.  The replay pin number is 13753335. A webcast replay will also be available on the investor relations section of Canadian Solar’s at www.canadiansolar.com.

About Canadian Solar Inc. 

Canadian Solar is one of the world’s largest solar technology and renewable energy companies. Founded in 2001 and headquartered in Kitchener, Ontario, the Company is a leading manufacturer of solar photovoltaic modules; provider of solar energy and battery energy storage solutions; and developer, owner, and operator of utility-scale solar power and battery energy storage projects. Over the past 24 years, Canadian Solar has successfully delivered nearly 150 GW of premium-quality, solar photovoltaic modules to customers across the world. Through its subsidiary e-STORAGE, Canadian Solar has shipped over 10 GWh of battery energy storage solutions to global markets as of December 31, 2024, boasting a US$3.2 billion contracted backlog as of December 31, 2024. Since entering the project development business in 2010, Canadian Solar has developed, built, and connected approximately 11.5 GWp of solar power projects and 4.5 GWh of battery energy storage projects globally. Its geographically diversified project development pipeline includes 25 GWp of solar and 75 GWh of battery energy storage capacity in various stages of development. Canadian Solar is one of the most bankable companies in the solar and renewable energy industry, having been publicly listed on the NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com.

CANADIAN SOLAR INC. INVESTOR RELATIONS CONTACT

Wina Huang
Investor Relations
Canadian Solar Inc.
investor@canadiansolar.com